Our Team

Mission

In pursuit of delivering patients the fastest possible visual restoration gene therapy

More than a million patients worldwide with inherited retinal disease are still waiting for an effective treatment that can end their fear of going blind.
Seeing them firsthand, a mission-driven ophthalmologist founded Restore Vision to develop a gene therapy to stop—even reverse—the disease in its tracks.
We can see a future where this too will be a treatable condition. And we want you to see it too.

Leadership

  • Yusaku Katada, MD, PhD

    Yusaku Katada MD, PhD

    CEO/CMO
  • Hikaru Miyazaki

    Hikaru Miyazaki

    COO
  • Yuko Fukushima

    Yuko Fukushima CPA

    CAO
  • Taka Tadokoro

    Taka Tadokoro MD, PhD

    CSO

Advisers

  • Hitoshi Kawamura PhD

    Hitoshi Kawamura PhD

    R&D advisor
  • Tsutomu Uchiyama PhD

    Tsutomu Uchiyama PhD

    IP Strategy Advisor
  • Ken Shimokawa PhD

    Ken Shimokawa PhD

    Strategic Advisor
  • Andra Miller PhD

    Andra Miller PhD

    CMC Advisor
  • Emi Mitsuya

    Emi Mitsuya

    Language Advisor
  • Emi Mitsuya

    Elizabeth K. Messersmith PhD

    Consultant, Clinical Dev. and R&D Strategy
  • Emi Mitsuya

    Tetsu Yung PhD, MBA

    Consultant, Project Management
  • Hideki Kandori

    Hideki Kandori PhD

    Scientific Advisor
  • Mark Penessi MD, PhD

    Mark Pennesi MD, PhD

    Scientific Advisor
  • Michel Michaelides MD

    Michel Michaelides MD

    Scientific Advisor
  • Rajendra S. Apte, MD, PhD

    Rajendra S. Apte, MD, PhD

    Scientific Advisor
  • Peter K. Kaiser, MD

    Peter K. Kaiser, MD

    Scientific Advisor

Investors

About Us

Company Name Restore Vision Inc.
Location
Headquarters
Toranomon Hills Business Tower 15F, 1-17-1 Toranomon, Minato-ku, Tokyo
Kobe Office
Kobe Hybrid Business Center (KHBC), 6-7-6 Minato-jima Minami-machi, Chuo-ku, Kobe-City, Hyogo
Established November 14, 2016
Representative Yusaku Katada MD, PhD
Hikaru Miyazaki
Business Activities Research and development of regenerative medicine